168 related articles for article (PubMed ID: 4149297)
1. Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine.
Saxena PR; de Vlaam-Schluter GM
Headache; 1974 Jan; 13(4):142-63. PubMed ID: 4149297
[No Abstract] [Full Text] [Related]
2. The effects of antimigraine drugs on the vascular responses by-5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action.
Saxena PR
Headache; 1972 Jul; 12(2):44-54. PubMed ID: 5056178
[No Abstract] [Full Text] [Related]
3. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P
Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of drugs applicable to treatment of migraine in the cranial circulation of the monkey.
Lance JW; Spira PJ; Mylecharane EJ; Lord GD; Duckworth JW
Res Clin Stud Headache; 1978; 6():13-8. PubMed ID: 103151
[No Abstract] [Full Text] [Related]
5. The effects of humoral agents and antimigraine drugs on the cranial circulation of the monkey.
Spira PJ; Mylecharane EJ; Lance JW
Res Clin Stud Headache; 1976; 4():37-75. PubMed ID: 818690
[No Abstract] [Full Text] [Related]
6. Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect.
Saxena PR
Eur J Pharmacol; 1974 Jun; 27(1):99-105. PubMed ID: 4854225
[No Abstract] [Full Text] [Related]
7. The animal pharmacology of drugs used in the treatment of migraine.
Fozard JR
J Pharm Pharmacol; 1975 May; 27(5):297-321. PubMed ID: 239131
[No Abstract] [Full Text] [Related]
8. Selective carotid vasoconstriction by ergotamine as a relevant mechanism in its antimigraine action.
Saxena PR
Arch Neurobiol (Madr); 1974; 37 SUPPL():301-15. PubMed ID: 4462487
[No Abstract] [Full Text] [Related]
9. Effects of methysergide, pizotifen and ergotamine in the monkey cranial circulation.
Mylecharane EJ; Spira PJ; Misbach J; Duckworth JW; Lance JW
Eur J Pharmacol; 1978 Mar; 48(1):1-9. PubMed ID: 416960
[TBL] [Abstract][Full Text] [Related]
10. Ergotamine and methysergide as serotonin partial agonists in migraine.
Fanciullacci M; Granchi G; Sicuteri F
Headache; 1976 Nov; 16(5):226-31. PubMed ID: 977328
[No Abstract] [Full Text] [Related]
11. [Classification, pathogenesis and drug therapy of migraine and related forms of headache].
Fanchamps A
Med Welt; 1975 Aug; 6(35):1518-23. PubMed ID: 241000
[No Abstract] [Full Text] [Related]
12. Some new vascular and biochemical aspects of the mechanism of action of ergot compounds.
Berde B
Headache; 1972 Jan; 11(4):139-47. PubMed ID: 4400045
[No Abstract] [Full Text] [Related]
13. Simultaneous measurement of internal and external carotid blood flow in the monkey. An approach to the study of migraine mechanisms.
Welch KM; Spira PJ; Knowles L; Lance JW
Neurology; 1974 May; 24(5):450-7. PubMed ID: 4207992
[No Abstract] [Full Text] [Related]
14. [Pathogenesis of migraine and mode of action of antimigraine agents].
Fanchamps A
Rev Med Suisse Romande; 1975 Dec; 95(12):917-42. PubMed ID: 781773
[No Abstract] [Full Text] [Related]
15. [Serotonin agonists and antagonists in migraine].
Ollat H
Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of action of drugs currently used in the prevention of migraine].
Fanchamps A
Minerva Med; 1976 Jun; 67(28):1858-60. PubMed ID: 59325
[TBL] [Abstract][Full Text] [Related]
17. Current concepts in the pathogenesis and interval treatment of migraine.
Anthony M; Lance JW
Drugs; 1972; 3(3):153-8. PubMed ID: 4403461
[No Abstract] [Full Text] [Related]
18. Antimigraine drugs and cranial arteriovenous shunting in the cat.
Spierings EL; Saxena PR
Neurology; 1980 Jul; 30(7 Pt 1):696-701. PubMed ID: 7190237
[TBL] [Abstract][Full Text] [Related]
19. Agonists and antagonists of vascular receptors.
Saxena PR
Adv Neurol; 1982; 33():309-14. PubMed ID: 7034489
[No Abstract] [Full Text] [Related]
20. Effects of low doses of clonidine in the monkey cranial circulation.
Mylecharane EJ; Duckworth JW; Lord GD; Lance JW
Eur J Pharmacol; 1980 Nov; 68(2):163-73. PubMed ID: 7202484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
